← Back to Search

Physical Activity Program for Reducing Blood Pressure in Sleep Apnea Patients With Resistant Hypertension (RAP Trial)

N/A
Waitlist Available
Led By Jean-Louis Pépin, Pr MD PhD
Research Sponsored by AGIR à Dom
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up to baseline at 12 weeks
Awards & highlights
No Placebo-Only Group

Summary

Investigators hypothesize that CPAP treatment for suppressing OSAS in combination with a physical activity program will optimize 24-hour blood pressure control in patients with OSA-related resistant hypertension.

Eligible Conditions
  • Sleep Apnea
  • Hypertension

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~to baseline at 12 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and to baseline at 12 weeks for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Systolic arterial blood pressure assessed by 24-hours home blood pressure monitoring
Secondary study objectives
Change in physical activity : Metabolic Equivalents (METS)
Change in physical activity : Number of steps per day
Change in physical activity: number of hour per day of physical activity
+4 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Physical activityExperimental Treatment1 Intervention
Obstructive sleep apnea and resistant hypertension controlled + physical activity
Group II: Control GroupActive Control1 Intervention
Obstructive sleep apnea and resistant hypertension controlled

Find a Location

Who is running the clinical trial?

University Hospital, GrenobleOTHER
831 Previous Clinical Trials
253,813 Total Patients Enrolled
12 Trials studying Hypertension
953 Patients Enrolled for Hypertension
AGIR à DomLead Sponsor
34 Previous Clinical Trials
5,000 Total Patients Enrolled
Jean-Louis Pépin, Pr MD PhDPrincipal InvestigatorLaboratoire EFCR, CHU de Grenoble, 38043, Grenoble, France
1 Previous Clinical Trials
50 Total Patients Enrolled
~9 spots leftby Jan 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top